Literature DB >> 11104189

Linkage exclusion in French families with probable Parkinson' s disease.

M Farrer1, T Destée, E Becquet, F Wavrant-De Vrièze, V Mouroux, F Richard, L Defebvre, S Lincoln, J Hardy, P Amouyel, M C Chartier-Harlin.   

Abstract

We analyzed the segregation of genetic markers spanning chromosomal regions 2p13, 4p14-15, 4q21-23, 6q25-27, and 17q21 in nine French families affected by autosomal-dominant probable Parkinson's disease. These regions have been linked or associated with familial Parkinson's disease. Multipoint linkage and haplotype analyses excluded 2p13 and 4p14-15 loci in five of nine families. For three families, which were equivocal for two-point linkage at D4S405, the ubiquitin carboxy-terminal hydrolase gene (UCH-L1) was sequenced. In one family, a novel UCH-L1 M124L mutation that did not segregate with early-onset disease was identified. This suggests that rare variants in this gene may not be pathogenic. In seven of nine families, it could be inferred that affected individuals did not share 4q21-23 (alpha-synuclein) haplotypes. All families were unequivocally excluded by haplotype analysis from the parkin locus on 6q25-27. Finally, the 17q21 region was excluded in four of nine families, and no mutation in the tau gene was identified in the five remaining families. Findings from this study confirm genetic heterogeneity within familial parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104189     DOI: 10.1002/1531-8257(200011)15:6<1075::aid-mds1004>3.0.co;2-2

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

Review 1.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

2.  Translation initiator EIF4G1 mutations in familial Parkinson disease.

Authors:  Marie-Christine Chartier-Harlin; Justus C Dachsel; Carles Vilariño-Güell; Sarah J Lincoln; Frédéric Leprêtre; Mary M Hulihan; Jennifer Kachergus; Austen J Milnerwood; Lucia Tapia; Mee-Sook Song; Emilie Le Rhun; Eugénie Mutez; Lydie Larvor; Aurélie Duflot; Christel Vanbesien-Mailliot; Alexandre Kreisler; Owen A Ross; Kenya Nishioka; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Heather L Melrose; Bahareh Behrouz; Brett H Keeling; Justin A Bacon; Emna Hentati; Lindsey Williams; Akiko Yanagiya; Nahum Sonenberg; Paul J Lockhart; Abba C Zubair; Ryan J Uitti; Jan O Aasly; Anna Krygowska-Wajs; Grzegorz Opala; Zbigniew K Wszolek; Roberta Frigerio; Demetrius M Maraganore; David Gosal; Tim Lynch; Michael Hutchinson; Anna Rita Bentivoglio; Enza Maria Valente; William C Nichols; Nathan Pankratz; Tatiana Foroud; Rachel A Gibson; Faycal Hentati; Dennis W Dickson; Alain Destée; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

Review 3.  Model fusion, the next phase in developing animal models for Parkinson's disease.

Authors:  Amy B Manning-Bog; J William Langston
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 4.  Impact of gene mutation in the development of Parkinson's disease.

Authors:  Suganya Selvaraj; Shanmughavel Piramanayagam
Journal:  Genes Dis       Date:  2019-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.